Over 350 delegates representing global pharmaceutical organisations, leading biotechnology companies, and internationally renowned academic institutions. Over 40+ presentations, case studies and panel discussions focussed on Cell & Gene Therapy development and clinical research for oncology and rare disease, the commercialisation of CAR T treatments, and Cell & Gene Therapy bioprocessing and manufacturing strategies.
Topics: Cell & Gene Therapy, Cell & Gene Therapy Treatments, Drug Development, Drug Development for Oncology, Rare Diseases, Bioprocessing